# Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

> **NCT04727671** · PHASE4 · COMPLETED · sponsor: **Damascus University** · enrollment: 50 (actual)

## Conditions studied

- In Vitro Fertilization
- Intracytoplasmic Sperm Injection
- Infertility
- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Triptorelin acetate
- **DRUG:** Cetrorelix
- **DRUG:** recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin
- **DRUG:** Human Chorionic Gonadotropin (hCG)

## Key facts

- **NCT ID:** NCT04727671
- **Lead sponsor:** Damascus University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-22
- **Primary completion:** 2021-08-15
- **Final completion:** 2021-12-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04727671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04727671, "Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04727671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*